Investments in Blood PDF Download

Author: G. A. Endless
Publisher:
ISBN: 9781920468224
Category : Electronic books
Languages : en
Pages : 428

View

Book Description

Author: Frank Ledwidge
Publisher: Yale University Press
ISBN: 0300194889
Category : History
Languages : en
Pages : 283

View

Book Description
"In this follow-up to his much-praised book Losing Small Wars: British Military Failure in Iraq and Afghanistan, Frank Ledwidge argues that Britain has paid a heavy cost - both financially and in human terms - for its involvement in the Afghanistan war. Ledwidge calculates the high price paid by British soldiers and their families, taxpayers in the United Kingdom, and, most importantly, Afghan citizens, highlighting the thousands of deaths and injuries, the enormous amount of money spent bolstering a corrupt Afghan government, and the long-term damage done to the British military's international reputation. In this hard-hitting exposé, based on interviews, rigorous on-the-ground research, and official information obtained through the Freedom of Information Act, Ledwidge demonstrates the folly of Britain's extended participation in an unwinnable war. Arguing that the only true beneficiaries of the conflict are development consultants, international arms dealers, and Afghan drug kingpins, he provides a powerful, eye-opening, and often heartbreaking account of military adventurism gone horribly wrong."--

Author: James Dale Davidson
Publisher: Grand Central Pub
ISBN: 9780446353168
Category : Fiction
Languages : en
Pages : 466

View

Book Description
The authors discuss a new way of judging and interpreting global events as the necessary context of investment strategy

Author: James Dale Davidson
Publisher:
ISBN: 9780283998096
Category : Economic history
Languages : en
Pages : 386

View

Book Description

Author: Charles Gasparino
Publisher: Simon and Schuster
ISBN: 0743276515
Category : Business & Economics
Languages : en
Pages : 339

View

Book Description
Blood on the Street is a riveting account of the Wall Street scam in which ordinary investors lost literally billions of dollars -- in many cases their life savings -- in one of the greatest deceptions ever, by the crack reporter who broke the original story. In one of the most outrageous examples of dirty dealing in the history of Wall Street, hundreds of millions of dollars in illicit profits were made during the booming 1990s as a result of research analysts issuing positive stock ratings on companies that kicked back investment banking business. Now, for the first time, award-winning journalist Charles Gasparino reveals the whole fascinating story of greed, arrogance, and corruption. It was Gasparino's front-page reporting in The Wall Street Journal that brought the story to national attention and spurred New York State attorney general Eliot Spitzer to launch an official probe. Now, Gasparino goes behind his own headlines to tell the inside story of this spectacular swindle -- with revelations from his unprecedented access to never-before-published depositions and documents, including e-mail exchanges leading all the way up to Citigroup CEO Sanford Weill. Drawing on his research and interviews with industry insiders, Gasparino takes readers into the back rooms of Wall Street's top investment firms and captures the outsize personalities of three key players: Salomon Smith Barney's Jack Grubman, a braggart with one of the largest salaries on Wall Street; Merrill Lynch's Henry Blodget, the Yale graduate who hyped his way to the top of the research pyramid; and Morgan Stanley's Mary Meeker, the "Queen of the Internet," who foresaw the market catastrophe but gave in to the pressures Blood on the Street shows how regulators, like former SEC chairman Arthur Levitt, allowed the deceptive practices to fester and grow during the 1990s bubble, leaving the door open for a then- little-known attorney general from New York State to step in and make his mark by holding Wall Street accountable. Gasparino provides the first major account of Spitzer's rise to prominence, detailing how the attorney general pursued key players to build his case against Wall Street, including his shifting allegiance to the powerful New York Stock Exchange chairman Richard Grasso. A fast-paced narrative rich in sharp insights, Blood on the Street is the definitive book on the financial debacle that affected millions of Americans.

Author: John Carreyrou
Publisher: Vintage
ISBN: 1524731668
Category : Business & Economics
Languages : en
Pages : 354

View

Book Description
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword covering her trial and sentencing, bringing the story to a close. “Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.

Author: Rose George
Publisher: Metropolitan Books
ISBN: 162779638X
Category : Science
Languages : en
Pages : 230

View

Book Description
An eye-opening exploration of blood, the lifegiving substance with the power of taboo, the value of diamonds and the promise of breakthrough science Blood carries life, yet the sight of it makes people faint. It is a waste product and a commodity pricier than oil. It can save lives and transmit deadly infections. Each one of us has roughly nine pints of it, yet many don’t even know their own blood type. And for all its ubiquitousness, the few tablespoons of blood discharged by 800 million women are still regarded as taboo: menstruation is perhaps the single most demonized biological event. Rose George, author of The Big Necessity, is renowned for her intrepid work on topics that are invisible but vitally important. In Nine Pints, she takes us from ancient practices of bloodletting to the breakthough of the "liquid biopsy," which promises to diagnose cancer and other diseases with a simple blood test. She introduces Janet Vaughan, who set up the world’s first system of mass blood donation during the Blitz, and Arunachalam Muruganantham, known as “Menstrual Man” for his work on sanitary pads for developing countries. She probes the lucrative business of plasma transfusions, in which the US is known as the “OPEC of plasma.” And she looks to the future, as researchers seek to bring synthetic blood to a hospital near you. Spanning science and politics, stories and global epidemics, Nine Pints reveals our life's blood in an entirely new light. Nine Pints was named one of Bill Gates recommended summer reading titles for 2019.

Author: Kandice A. Kapinos
Publisher:
ISBN:
Category :
Languages : en
Pages : 6

View

Book Description
RAND studied trends affecting public cord blood banks and considered changes to the program to buttress banks’ financial stability. Researchers found a system worthy of investment, especially if it helps improve the quality of the national inventory.

Author: Ian Smillie
Publisher: Anthem Press
ISBN: 085728987X
Category : History
Languages : en
Pages : 252

View

Book Description
Africa’s diamond wars took four million lives. ‘Blood on the Stone’ tells the story of how diamonds came to be so dangerous, describing the great diamond cartel and a dangerous pipeline leading from war-torn Africa to the glittering showrooms of Paris, London and New York. It describes the campaign that forced an industry and more than 50 governments to create a global control mechanism, and it provides a sobering prognosis on its future.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241564865
Category : Medical
Languages : en
Pages : 211

View

Book Description
"The presence, or absence, of neglected tropical diseases (NTDs) can be seen as a proxy for poverty and for the success of interventions aimed at reducing poverty. Today, coverage of the public-health interventions recommended by the World Health Organization (WHO) against NTDs may be interpreted as a proxy for universal health coverage and shared prosperity - in short, a proxy for coverage against neglect. As the world's focus shifts from development to sustainable development, from poverty eradication to shared prosperity, and from disease-specific goals to universal health coverage, control of NTDs will assume an important role towards the target of achieving universal health coverage, including individual financial risk protection. Success in overcoming NTDs is a "litmus test" for universal health coverage against NTDs in endemic countries. The first WHO report on NTDs (2010) set the scene by presenting the evidence for how these interventions had produced results. The second report (2013) assessed the progress made in deploying them and detailed the obstacles to their implementation. This third report analyses for the first time the investments needed to achieve the scale up of implementation required to achieve the targets of the WHO Roadmap on NTDs and universal coverage against NTDs. INVESTING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES presents an investment strategy for NTDs and analyses the specific investment case for prevention, control, elimination and eradication of 12 of the 17 NTDs. Such an analysis is justified following the adoption by the Sixty-sixth World Health Assembly in 2013 of resolution WHA6612 on neglected tropical diseases, which called for sufficient and predictable funding to achieve the Roadmap's targets and sustain control efforts. The report cautions, however, that it is wise investment and not investment alone that will yield success. The report registers progress and challenges and signals those that lie ahead. Climate change is expected to increase the spread of several vector-borne NTDs, notably dengue, transmission of which is directly influenced by temperature, rainfall, relative humidity and climate variability primarily through their effects on the vector. Investments in vector-borne diseases will avoid the potentially catastrophic expenditures associated with their control. The presence of NTDs will thereby signal an early warning system for climate-sensitive diseases. The ultimate goal is to deliver enhanced and equitable interventions to the most marginalized populations in the context of a changing public-health and investment landscape to ensure that all peoples affected by NTDs have an opportunity to lead healthier and wealthier lives."--Publisher's description.